Determinants of survival following HIV-1 seroconversion after the introduction of HAART.

BACKGROUND: Highly active antiretroviral therapy (HAART) was introduced in 1997. We aimed to assess the continuing effect of this treatment on survival and progression to AIDS after HIV-1 seroconversion. METHODS: We used Cox models to estimate the effect of calendar year on time to AIDS and death i...

Descripción completa

Detalles Bibliográficos
Autores principales: Porter, K, Babiker, A, Bhaskaran, K, Darbyshire, J, Pezzotti, P, Walker, A
Formato: Journal article
Lenguaje:English
Publicado: 2003